Stocktoria
Revolution Medicines, Inc. RVMD
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-02-13
Chart by TradingView
1/9
Piotroski F — financial health
-0.01
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Valuation · market cap as of 2026-06-29
Market cap$38.7B
P / B23.7×
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $0 | $0 | $11.6M | $35.4M | $29.4M |
| Operating income | -$1.2B | -$689.5M | -$487.2M | -$258.3M | -$188.0M |
| Net income | -$1.1B | -$600.1M | -$436.4M | -$248.7M | -$187.1M |
| Operating cash flow | -$897.7M | -$557.4M | -$350.6M | -$224.4M | -$147.2M |
| Free cash flow | -$913.7M | -$567.7M | -$358.3M | -$235.2M | -$153.7M |
| Total assets | $2.4B | $2.6B | $2.1B | $811.9M | $738.0M |
| Total liabilities | $723.2M | $293.1M | $235.5M | $126.7M | $135.4M |
| Shareholders' equity | $1.6B | $2.3B | $1.8B | $685.2M | $602.6M |
| Ratios | |||||
| Operating margin | — | — | -4207.1% | -730.0% | -639.7% |
| Net margin | — | — | -3768.3% | -703.0% | -636.6% |
| FCF margin | — | — | -3094.1% | -664.8% | -523.0% |
| Return on assets | -48.0% | -23.5% | -21.2% | -30.6% | -25.4% |
| Return on equity | -69.3% | -26.5% | -23.9% | -36.3% | -31.0% |
| Current ratio | 7.14 | 14.20 | 13.06 | 10.65 | 9.77 |
| Revenue growth | — | -100.0% | -67.3% | 20.4% | -31.6% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 6,200 | $602,950 |
| Point72 Asset Management, L.P. | 2,600 | $252,850 |
| Duquesne Family Office LLC | 315,860 | $30,717 |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -0.01 (distress)
- Working capital / assets 0.758
- Retained earnings / assets -1.219
- EBIT / assets -0.502
- Equity / liabilities 2.256
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001628171 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.